Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma

NCT00280007 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
32
Enrollment
OTHER
Sponsor class

Stopped Safety concerns in the treatment arm

Conditions

Interventions

Sponsor

Medical University of Vienna